AlphaCentric Advisors’s Oscar Health OSCR Stock Holding History

AlphaCentric Advisors’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,500	Closed	-$148K	–	234
2021 Q1	$148K	Buy	+5,500	New	+$172K	0.05%	117

Other funds holding OSCR

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

FFIM

Founders Fund IV Management San Francisco, California $1.21M AUM

Formation8 Los Altos, California $67.6M AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

AlphaCentric Advisors's OSCR Position: Q2 2021 in Review

AlphaCentric Advisors sold out of Oscar Health (OSCR) in Q2 2021, closing a stake of 5,500 shares — an estimated $148K sold.

AlphaCentric Advisors first reported a position in OSCR in Q1 2021 and held it in 1 quarter. The position peaked at $148K in Q1 2021. 77 funds tracked by Wall St. Rank hold OSCR as of Q2 2021.

AlphaCentric Advisors reported no remaining Oscar Health position as of Q2 2021 after selling out during the quarter.
AlphaCentric Advisors sold 5,500 Oscar Health shares in Q2 2021, an estimated $148K.
AlphaCentric Advisors first reported a position in Oscar Health in Q1 2021 and held it in 1 quarter.
AlphaCentric Advisors's Oscar Health position peaked at $148K in Q1 2021.
77 funds tracked by Wall St. Rank held Oscar Health as of Q2 2021.

Based on AlphaCentric Advisors's 13F filing for Q2 2021, filed 9 Mar 2022.